5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole

C21H21IrN9-2 — CID 58479909

IUPAC5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole
SMILESCc1nc(-n2ncnc2C2[C-]=NC=N2)n(C)c1C.Cn1ccnc1-c1[c-]cccc1.[Ir]
InChIInChI=1S/C11H12N7.C10H9N2.Ir/c1-7-8(2)17(3)11(16-7)18-10(14-6-15-18)9-4-12-5-13-9;1-12-8-7-11-10(12)9-5-3-2-4-6-9;/h5-6,9H,1-3H3;2-5,7-8H,1H3;/q2*-1;
InChIKeyHZDZVFPWSUGOJC-UHFFFAOYSA-N
MW591.68 g/mol
LogP2.53
Rot. Bonds3

About 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole

5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole (PubChem CID 58479909) has the molecular formula C21H21IrN9-2 and a molecular weight of 591.68 g/mol. Its IUPAC name is 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole.

Molecular Properties

Compound Name5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole
PubChem CID58479909
Molecular FormulaC21H21IrN9-2
Molecular Weight591.68 g/mol
Exact Mass592.16
IUPAC Name5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole
SMILESCc1nc(-n2ncnc2C2[C-]=NC=N2)n(C)c1C.Cn1ccnc1-c1[c-]cccc1.[Ir]
InChIInChI=1S/C11H12N7.C10H9N2.Ir/c1-7-8(2)17(3)11(16-7)18-10(14-6-15-18)9-4-12-5-13-9;1-12-8-7-11-10(12)9-5-3-2-4-6-9;/h5-6,9H,1-3H3;2-5,7-8H,1H3;/q2*-1;
InChIKeyHZDZVFPWSUGOJC-UHFFFAOYSA-N
XLogP2.53
TPSA91.07 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds3
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500591.68
LogP ≤ 52.53
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole?
The IUPAC name of 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole (CID 58479909) is 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole.
What is the SMILES notation for 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole?
The canonical SMILES for 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole is Cc1nc(-n2ncnc2C2[C-]=NC=N2)n(C)c1C.Cn1ccnc1-c1[c-]cccc1.[Ir].
What is the InChIKey of 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole?
The InChIKey is HZDZVFPWSUGOJC-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H12N7.C10H9N2.Ir/c1-7-8(2)17(3)11(16-7)18-10(14-6-15-18)9-4-12-5-13-9;1-12-8-7-11-10(12)9-5-3-2-4-6-9;/h5-6,9H,1-3H3;2-5,7-8H,1H3;/q2*-1;.
What are the key properties of 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole?
5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole has a molecular weight of 591.68 g/mol, XLogP of 2.53, 3 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(4,5-dihydroimidazol-5-id-4-yl)-1-(1,4,5-trimethylimidazol-2-yl)-1,2,4-triazole;iridium;1-methyl-2-phenylimidazole is sourced from PubChem (CID 58479909), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).